S. B. Kim

439 total citations
8 papers, 85 citations indexed

About

S. B. Kim is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. B. Kim has authored 8 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. B. Kim's work include Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Structural Health Monitoring Techniques (1 paper). S. B. Kim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Structural Health Monitoring Techniques (1 paper). S. B. Kim collaborates with scholars based in South Korea, United States and Belgium. S. B. Kim's co-authors include Hoon Sohn, Jong‐Lyel Roh, Chang Hwan Ryu, Soon Yuhl Nam, Seong‐Wook Lee, Yong Sik Kim, Jeong Eon Lee, Ningning Ding, Kyu Hun Choi and Eric Van Cutsem and has published in prestigious journals such as Annals of Oncology, Journal of Medical Internet Research and Metallurgical and Materials Transactions A.

In The Last Decade

S. B. Kim

6 papers receiving 83 citations

Peers

Countries citing papers authored by S. B. Kim

Since Specialization

Citations

This map shows the geographic impact of S. B. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. B. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. B. Kim more than expected).

Fields of papers citing papers by S. B. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. B. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. B. Kim. The network helps show where S. B. Kim may publish in the future.

Co-authorship network of co-authors of S. B. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of S. B. Kim. A scholar is included among the top collaborators of S. B. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. B. Kim. S. B. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Clinical Efficacy of Smartphone App–Based Pulmonary Rehabilitation in Chronic Respiratory Diseases: Randomized Controlled and Feasibility Trials 2025 ·Journal of Medical Internet Research ·(unknown), Ah‐Ram Kim, Do‐Yoon Kang, S. B. Kim, Jin Young Oh, Hui Jung Kim, (unknown), (unknown), Dongbum Kim, Hee Kwon, Min‐Woo Jo, Sei Won Lee	0
2	Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life 2022 ·ESMO Open ·Eric Van Cutsem, Kazuaki Kato, Jaffer A. Ajani, Lin Shen, (unknown), Ningning Ding, (unknown), (unknown), S. B. Kim	17
3	MonarcHER: A randomized phase II study of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with HR+, HER2+ advanced breast cancer (ABC) 2019 ·Annals of Oncology ·SM Tolaney, Andrew Wardley, Stefania Zambelli, John Hilton, Tiffany A. Troso-Sandoval, Francesco Ricci, S.-A. Im, S. B. Kim, S. Johnston, Arlene Chan, Shom Goel, (unknown), Zhengyu Yang, (unknown), Fabrice André	19
4	First-line cobimetinib (C) + paclitaxel (P) in patients (pts) with advanced triple-negative breast cancer (TNBC): Updated results and tumoral immune cell infiltration data from the phase 2 COLET study 2016 ·Annals of Oncology ·David Miles, S. B. Kim, Thierry Velu, José Á. García-Sáenz, Elizabeth Tan-Chiu, (unknown), Luc Dirix, (unknown), Marleen Borms, (unknown), (unknown), (unknown), Mark Kozloff, Joseph A. Sparano, (unknown), (unknown), (unknown), Brian Simmons, Virginia McNally, Adam Brufsky	0
5	Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma 2012 ·Annals of Oncology ·Chang Hwan Ryu, Jong‐Lyel Roh, S. B. Kim, Seong‐Wook Lee, (unknown), Soon Yuhl Nam, (unknown)	23
6	Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison 2011 ·Nephrology Dialysis Transplantation ·Jeong Eon Lee, (unknown), Kyu Hun Choi, S. B. Kim, Yong Sik Kim, (unknown), (unknown), Daehan Kim	13
7	Continuous fatigue crack monitoring without baseline data 2008 ·Fatigue & Fracture of Engineering Materials & Structures ·S. B. Kim, Hoon Sohn	9
8	Effect of Primary Grain Sizeon the Secondary Recrystallization of Mechanically Alloyed Oxide Dispersion Strengthened Ni-Base Superalloy 1996 ·Metallurgical and Materials Transactions A ·(unknown), S. B. Kim, Yong‐Gil Kim, Soon Hyung Hong, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact